Algert Global LLC Iveric Bio, Inc. Transaction History

Algert Global LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $2.4 Million - $3.62 Million	-91,340 Reduced 64.12%	51,101 $2.01 Million
Q1 2023 May 12, 2023	SELL	$18.67 - $24.56 $269,949 - $355,113	-14,459 Reduced 9.22%	142,441 $3.47 Million
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $401,864 - $558,274	-23,310 Reduced 12.93%	156,900 $3.36 Million
Q3 2022 Nov 15, 2022	BUY	$9.4 - $18.59 $147,974 - $292,643	15,742 Added 9.57%	180,210 $3.23 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $1.07 Million - $2.22 Million	117,390 Added 249.35%	164,468 $1.58 Million

Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $397,718 - $550,913	32,734 Added 228.21%	47,078 $792,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $237,557 - $322,584	-17,177 Reduced 54.49%	14,344 $240,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $71,152 - $176,120	10,064 Added 46.9%	31,521 $512,000
Q2 2021 Aug 13, 2021	SELL	$5.69 - $7.17 $245,182 - $308,955	-43,090 Reduced 66.76%	21,457 $135,000
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $690,747 - $936,860	-135,974 Reduced 67.81%	64,547 $399,000
Q4 2020 Feb 12, 2021	SELL	$5.65 - $7.66 $66,331 - $89,928	-11,740 Reduced 5.53%	200,521 $1.39 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $665,688 - $1.04 Million	166,007 Added 358.9%	212,261 $1.2 Million
Q2 2020 Aug 12, 2020	BUY	$3.06 - $6.6 $27,797 - $59,954	9,084 Added 24.44%	46,254 $236,000
Q1 2020 May 13, 2020	BUY	$2.83 - $8.44 $105,191 - $313,714	37,170 New	37,170 $128,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.